Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans.
about
Emerging therapies for patients with symptoms of opioid-induced bowel dysfunctionDose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogsTreatment of opioid-induced gut dysfunctionVgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide.Opioid receptors in the gastrointestinal tract.Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.Emerging drugs for postoperative ileus.New approaches to the treatment of opioid-induced constipation.Methylnaltrexone bromide: research update of pharmacokinetics following parenteral administration.Opioid-induced constipation in advanced illness: safety and efficacy of methylnaltrexone bromide.Methylnaltrexone for the treatment of opioid-induced constipation.Protease inhibitor-induced nausea and vomiting is attenuated by a peripherally acting, opioid-receptor antagonist in a rat modelMethylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activity.
P2860
Q27010907-7F463D6F-AF03-42CD-8E8D-7E3329DF82D8Q28264794-BB252E85-9FD0-43B5-84A9-778E7F34CAF1Q28284578-FFDDC083-45B5-4182-9D8F-BE8828A7F9FEQ33296232-C742F2CA-4F19-45D9-BABA-02D9D95EA5FEQ33715430-80919270-6F96-4B22-91F5-A80BE8BC2CE4Q35185222-D28724AC-0E14-4F2F-BE25-05348EB6EC85Q36458384-69DF7C26-AA7E-4001-A368-2FED3B127022Q36989931-0EECCD91-2FC4-4BB9-BA93-546AEDF801CFQ37299608-DA086E88-39B1-4EA7-A026-C46F391BDD11Q37827493-84E9028B-E578-40FC-96E1-4925EFFB9CBFQ37916266-184F30C6-3D93-4500-800E-841A2119E077Q38069607-A68F996A-C0A5-4AB2-B992-17EE50DBD8D3Q42014740-6011B0ED-D9B9-45D4-969F-B09649C6763BQ43266400-FA21D3B1-3839-4C69-B778-D87BCBE109F8Q44338510-D642508D-DD10-4109-828F-8801C6F7C051
P2860
Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans.
@en
Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans.
@nl
type
label
Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans.
@en
Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans.
@nl
prefLabel
Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans.
@en
Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans.
@nl
P2093
P2860
P1433
P1476
Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans.
@en
P2093
A N Kotake
L I Goldberg
S K Kuwahara
P2860
P304
P356
10.3109/00498258909043176
P407
P577
1989-11-01T00:00:00Z